Congenital toxoplasmosis is a serious disease that occurs when the Toxoplasma gondii parasite crosses the placental barrier and affects the fetus during pregnancy. The severity of the disease may be associated with the type of strain acquired, the immune status of the mother, and the gestational period in which maternal infection and fetal transmission occurs (1) (2) .
Among the different types of antibodies, the anti-Toxoplasma gondii immunoglobulin G (IgG) and immunoglobulin M (IgM) are the most commonly reported among pregnant women worldwide (1) (3) , and the presence of anti-T. gondii antibodies is an important factor in determining the time of infection. IgA and IgM class antibodies are associated with recent infections (acute infection) while IgG class antibodies are associated with chronic infection (3) (4) (5) (6) . However, the individual analysis of these antibodies does not differentiate the time of infection as IgA and IgM antibodies may be detectable for several months or even be undetectable in acute infections, and thus searching for more than one type of antibody is required to confi rm the acute infection. In addition, the IgM antibody test is widely used to diagnose acute infections, as these antibodies usually appear 1 week after infection and may disappear within 6 months (7) (8) . However, the IgA antibody test is not commonly used, and most studies only use this test to detect the disease in cases of congenital infection. Thus, the IgA antibody test is an important marker for T. gondii infection in newborn babies. On the other hand, IgM antibodies during infection can arise at the beginning of pregnancy but be undetectable in the newborn serum at birth (6) (9) (10) . Furthermore, although the detection of IgA antibodies is similar to IgM antibodies, the peak titers of IgA antibodies occurs later (8) (10) . However, few studies, especially in Brazil, have described the behavior and use of IgA in the diagnosis of infection in pregnant women. Thus, considering the severity of toxoplasmosis during pregnancy and the contribution of serological diagnosis to identifying the disease, we aimed to investigate the frequency of anti-T. gondii IgM, IgA, and IgG antibodies to identify the incidence of infection during high- risk pregnancies among women attending a Brazilian National Health Service tertiary teaching hospital. Peripheral blood samples were collected in dry tubes to obtain serum and were stored at -20°C until used to test for IgM, IgA, and IgG antibodies against T. gondii. The reactions were performed using an enzyme-linked immunosorbent assay (ELISA) with the ETI-TOXOK-A (for IgA), ETI-TOXOK-G (for IgG), and ETI-TOXOK-M (for IgM) commercial assays (DiaSorin, Italy) according to the manufacturer's instructions.
The mean age of the pregnant women was 24.9 ± 6.9 (range: 14-43). Table 1 shows the results of the anti-T. gondii antibody analysis, and Table 2 shows the serological profi le of the T. gondii antibodies. IgM antibodies were more common than IgA antibodies (91.9% and 69.4%, respectively). However, IgA antibodies were detected without IgM antibodies in 4 samples (6.5%). This supports the results found by Fricker-Hidalgo et al., who found that 5 samples were positive for IgA but negative for IgM in pregnant women, as well as Roc et al., who identifi ed 9 samples from neonates that were positive for IgA, only three of which were also positive for IgM (11) (12) .
We also found that 10 (16.1%) samples were negative for IgA and IgM antibodies but were positive for IgG antibodies. These results may suggest reactivation of a past infection, but clinical and serological follow-up of these pregnant women as well as an IgG avidity test, which was not conducted in the current study, would be necessary to verify this hypothesis. Moreover, treatment of pregnant women can modify the results of serological tests, and this may have contributed to the negative results for the IgA and IgM classes of antibodies, as previously described (13) (14) . In addition, diagnosing toxoplasmosis in Brazil is diffi cult because there is no specifi c countrywide policy and no standard commercial assay to identify the type of infection hindering management of the different forms of the disease (1) (13) (15) (16) .
In France there are fl owcharts for interpretation of serological results in pregnant women to prevent congenital toxoplasmosis. Villard et al. proposed other fl owcharts for other forms of the disease, such as congenital toxoplasmosis, immunosuppressed situations, and ocular toxoplasmosis, highlighting the importance of the serological test chosen in identifying infection and the subsequent prevention of the disease. The authors also described the importance of the interpretation of the results and the association of IgA with IgM class antibodies characterizing acute infection (8) . However, in Brazil, most public health services do not perform more than one serological assay during antenatal care, and most of them do not offer an avidity assay to estimate the date of maternal infection. Nonetheless, the use of these laboratory assays performed during pregnancy can help guide clinical research and confi rm the presence or absence of acute maternal infection (6) (14) (16) .
In conclusion, our study showed that the identifi cation of anti-T. gondii IgA antibodies as well as routine testing for IgM and IgG antibodies can help diagnose toxoplasmosis during pregnancy thereby contributing to clinical management. 
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